搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
health enews
7 天
Nasal congestion on one side? You may have this condition
A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.
8 小时
It’s the illness that has no cure. But this doctor believes he’s found the answer to ...
Chronic fatigue and long Covid remain poorly understood, but Dr Perrin’s unusual techniques are having surprisingly positive ...
Onlymyhealth
9 天
From Allergies to Asthma, These Conditions Can Trigger Nasal Polyps
often resulting from chronic inflammation. While these benign growths themselves are not harmful, they can lead to ...
Monthly Prescribing Reference
6 天
Tezepelumab Reduces Nasal Congestion and Polyp Size in Chronic Rhinosinusitis
Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...
6 天
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
FiercePharma
5 天
AstraZeneca, Amgen's Tezspire scores in rhinosinusitis study
Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...
6 天
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...
9 天
on MSN
Seasonal allergies surge in Telangana, doctors advise precautionary measures
HYDERABAD: While the monsoon season saw an ambush of vector-borne diseases such as dengue and chikungunya in the state, ...
6 天
Amgen, AstraZeneca announce top-line results from WAYPOINT trial
Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...
5 天
AstraZeneca announces WAYPOINT trial met both co-primary endpoints
Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈